- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: LEO 43204 Formulation 2
Total 263 results
-
LEO PharmaCompletedActinic KeratosisCanada, United States
-
LEO PharmaCompletedActinic KeratosisUnited States
-
LEO PharmaCompletedActinic KeratosisUnited States
-
LEO PharmaCompleted
-
LEO PharmaCompletedActinic KeratosisUnited States
-
LEO PharmaCompleted
-
LEO PharmaCompletedActinic KeratosisUnited States
-
LEO PharmaCompletedActinic KeratosisUnited States
-
LEO PharmaCompleted
-
LEO PharmaCompletedActinic KeratosisUnited States
-
LEO PharmaTerminatedActinic Keratosis | Squamous Cell CarcinomaUnited States, Spain, Canada, Germany, France, United Kingdom
-
Sanofi Pasteur, a Sanofi CompanyImmune DesignTerminated
-
PfizerCompleted
-
Midwest Center for Metabolic and Cardiovascular...Pharmavite LLCCompletedBioavailabilityUnited States
-
AstraZenecaCompletedParkinson's DiseaseUnited Kingdom
-
GlaxoSmithKlineActive, not recruitingHerpes SimplexGermany, United States, Belgium, Canada, Spain, United Kingdom, Estonia, Australia
-
Boehringer IngelheimRecruitingHidradenitis SuppurativaUnited States, Korea, Republic of, Israel, Spain, Australia, Japan, Italy, Germany, Denmark, Belgium, Lithuania, China, Canada, Malaysia, Singapore, New Zealand, France, Mexico, Netherlands, Greece, United Kingdom, Bulgaria, Philipp... and more
-
Eli Lilly and CompanyCompleted
-
Vifor (International) Inc.Completed
-
ViiV HealthcareGlaxoSmithKlineCompletedHIV Infections | Infection, Human Immunodeficiency VirusUnited States
-
Boehringer IngelheimRecruitingSmall Cell Lung Carcinoma | Neuroendocrine NeoplasmsUnited States, Belgium, Spain, Korea, Republic of, United Kingdom, Germany, Japan, China, Taiwan, France, Portugal, Bulgaria
-
HK inno.N CorporationCompletedErosive EsophagitisKorea, Republic of
-
Boehringer IngelheimCompleted
-
Imperial Brands PLCNerudia LtdCompleted
-
Chong Kun Dang PharmaceuticalCompletedHypertensionKorea, Republic of
-
Atea Pharmaceuticals, Inc.Hoffmann-La RocheCompleted
-
MedImmune LLCCompletedType 2 Diabetes MellitusUnited States
-
Janssen Research & Development, LLCCompleted
-
PfizerActive, not recruitingHealthy ParticipantsUnited States
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineRecruiting
-
Sanofi Pasteur, a Sanofi CompanyTerminatedCOVID-19United States, Australia, Brazil, Honduras
-
Boehringer IngelheimCompleted
-
National Research Council, SpainHospital Universitario Reina Sofia de CordobaCompletedColorectal CancerSpain
-
Aragon Pharmaceuticals, Inc.Completed
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency Virus | Infections, Human Immunodeficiency Virus and HerpesviridaeUnited States
-
Pendulum TherapeuticsTerminatedType 2 Diabetes MellitusIreland
-
Boehringer IngelheimCompleted
-
Chong Kun Dang PharmaceuticalUnknownHypertension | DyslipidemiasKorea, Republic of
-
Emory UniversityMicron Biomedical, IncCompletedVaccination | Skin AbsorptionUnited States
-
Emergent BioSolutionsNational Institute of Allergy and Infectious Diseases (NIAID); Department of...CompletedBacillus Anthracis (Anthrax) InfectionUnited States
-
AllerganCompletedOcular Hypertension | Primary Open-Angle GlaucomaUnited States
-
GlaxoSmithKlineCompletedRespiratory Syncytial Virus InfectionsGermany, Estonia, Belgium, France
-
GlaxoSmithKlineCompleted
-
Chong Kun Dang PharmaceuticalUnknown
-
GlaxoSmithKlineActive, not recruiting
-
GlaxoSmithKlineCompletedRespiratory Syncytial Virus InfectionsUnited States, Belgium, Canada
-
GlaxoSmithKlineWithdrawnRespiratory Syncytial Virus InfectionsFinland, United States, Spain
-
TakedaCompletedDengue FeverUnited States
-
AstraZenecaCompletedUncontrolled and Persistent AsthmaUnited Kingdom